<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.alphainflection.com/market-news/fsn-e-commerce-nykaa-s-q2fy27-filing-pat-doubles-year-on-year-to-101-crore</loc>
    <news:news>
      <news:publication>
        <news:name>Alpha Inflection</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-06T08:58:59.005Z</news:publication_date>
      <news:title>Nykaa’s Q2FY27 filing: PAT doubles year-on-year to ₹101.19 crore; Fashion remains loss-making and cash flow turns negative</news:title>
    </news:news>
    <image:image>
      <image:loc>https://img.alphainflection.com/og/fsn-e-commerce-nykaa-s-q2fy27-filing-pat-doubles-year-on-year-to-101-crore-r2-16x9.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.alphainflection.com/market-news/keystone-realtor-q2fy27-operating-margin-climbs-to-29-but-h1-pre-sales-cover</loc>
    <news:news>
      <news:publication>
        <news:name>Alpha Inflection</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T09:03:35.588Z</news:publication_date>
      <news:title>Keystone Realtor Q2FY27: operating margin climbs to 29.4%, but H1 pre-sales cover only 41% of annual target</news:title>
    </news:news>
    <image:image>
      <image:loc>https://img.alphainflection.com/og/keystone-realtor-q2fy27-operating-margin-climbs-to-29-but-h1-pre-sales-cover-r1-16x9.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.alphainflection.com/market-news/alembic-pharma-q2fy27-operating-margin-climbs-to-22-as-us-formulations-revenue</loc>
    <news:news>
      <news:publication>
        <news:name>Alpha Inflection</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T09:03:27.444Z</news:publication_date>
      <news:title>Alembic Pharma Q2FY27: Operating margin climbs to 22.21% as US formulations revenue rises 77%</news:title>
    </news:news>
    <image:image>
      <image:loc>https://img.alphainflection.com/og/alembic-pharma-q2fy27-operating-margin-climbs-to-22-as-us-formulations-revenue-r1-16x9.png</image:loc>
    </image:image>
  </url>
</urlset>
